Darbatitor 25mcg Injection
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Darbepoetin alfa (25mcg)
Overview Darbatitor 25mcg Injection
Erythropoiesis-stimulating agent Darbatitor (25mcg injection) treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. Administered under strict medical supervision, Darbatitor demands careful use due to potential severe adverse effects. Consult an experienced physician for treatment and adhere rigorously to their instructions. Common side effects comprise abdominal discomfort, hypertension, rash, injection site pain, dyspnea, cough, and peripheral edema. Report symptoms of severe hypertension—intense headache, visual disturbances, nausea, vomiting, or convulsions—immediately. Regular blood tests (electrolytes like potassium, hemoglobin, and blood cell counts) will be conducted to monitor your condition. Discontinue use and seek medical attention for shortness of breath or skin rashes. Prior to commencing treatment, disclose any pre-existing heart disease, hypertension, seizure history, or stroke to your doctor. Pregnant, breastfeeding, or intending to become pregnant or breastfeed individuals must consult their physician regarding safety.
Uses of Darbatitor 25mcg Injection
Managing anemia in chronic kidney disease patients | Addressing chemotherapy-induced anemia
Major Benefits of Darbatitor 25mcg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Darbatitor 25mcg Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Darbatitor 25mcg Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strictly prohibited.
How Darbatitor 25mcg Injection works:
Darbatitor 25mcg Injection is an erythropoietin-based medication that boosts red blood cell production. Its mechanism of action involves stimulating the bone marrow's generation of red blood cells within the spongy bone tissue.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Darbatitor 25mcg Injection may pose unknown risks. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Darbatitor 25mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Administration of Darbatitor 25mcg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Administering Darbatitor 25mcg Injection typically does not impair driving ability.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Darbatitor 25mcg Injection is considered safe and requires no dosage modification.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Darbatitor 25mcg Injection. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Darbatitor 25mcg Injection :
Should you forget a Darbatitor 25mcg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Darbatitor 25mcg Injection
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Category | Erythropoietin-stimulating drug |
3,018 People bought this recently